RICARDO
9.5.2023 13:31:33 CEST | Business Wire | Press release
Ricardo, a global strategic environmental and engineering consulting company with specialisms in niche manufacturing and industrial engineering has announced a long-term, multi-year partnership with British supercar company McLaren Automotive to manufacture its next-generation V8 power unit.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230509005049/en/
Ricardo plc and McLaren Automotive announce long-term multi-year V8 engine supply agreement partnership for future high-performance hybrid powertrains. (Photo: Business Wire)
Designed in-house by McLaren’s powertrain team, the new high-performance V8 engine will power the next generation of lightweight, high-performance hybrid supercars as part of the company’s Future of Performance strategy.
This is the third extension and fourth generation of the engine supply agreement between the two companies. Ricardo has built both the V6 and V8 engines that will power McLaren’s existing and future high-performance hybrid supercars.
Since the introduction of McLaren’s first series production supercar, the 12C in 2011, Ricardo has produced over 34,000 McLaren powertrains at its purpose-built assembly facility at Shoreham-by-Sea in the UK, before delivering them to the McLaren Production Centre in Woking, in the UK, where McLaren designs and hand builds its supercars.
Under the terms of the agreement, Ricardo will supply both hybrid and non-hybrid variants. To support this, Ricardo and McLaren will make further investment in the high-performance engine production facility at Shoreham, with over 100 expert manufacturing engineers and technicians committed to supplying McLaren’s high-performance powertrains.
Graham Ritchie, Chief Executive Officer, Ricardo plc, said: “We are extremely pleased to have concluded this long-term multi-year engine supply agreement with McLaren Automotive, for its next generation high-performance V8 powertrain, which extends the long-term relationship between both companies into the next decade. Like McLaren, Ricardo has a proven track record of engineering excellence, delivering high performance technology and the highest standards of product quality supported by the upstream supply chain. With this agreement, we look forward to continuing our established and highly successful relationship with McLaren into its third decade.”
Michael Leiters, Chief Executive Officer, McLaren Automotive said: “Our new high-performance, hybrid V8 powertrain will form an integral part of McLaren’s next generation product line-up delivering best-in-class performance and thrilling driver engagement.”
“This new agreement with Ricardo is, therefore, an important part of our ‘Future of Performance’ strategy and builds on the enduring relationship between the two British companies, providing a boost for jobs and ensuring increased investment in what is a vitally important domestic engineering supply chain for future technologies.”
-Ends-
About Ricardo
Ricardo plc is a global strategic, environmental, and engineering consulting company, listed on the London Stock Exchange. With over 100 years of engineering excellence and employing close to 3,000 employees in more than 20 countries, we provide exceptional levels of expertise in delivering leading-edge and innovative cross-sector sustainable products and solutions. Every day, we enable our customers to solve the most complex and dynamic challenges to help achieve a safe and sustainable world. Visit www.ricardo.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230509005049/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom